Proteomic Case Studies of MDS in Progression: Heterogeneity and More Heterogeneity

Proteomic Case Studies of MDS in Progression: Heterogeneity and More Heterogeneity [Turk J Hematol]

Turk J Hematol. 2022; 39(4): 272-274 | DOI: 10.4274/tjh.galenos.2022.2022.0290

Proteomic Case Studies of MDS in Progression: Heterogeneity and More Heterogeneity

Klara Pecankova, Jaroslav Cermak, Pavel Majek
Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Keywords: Myelodysplastic syndrome, Plasma proteome, Proteomics

Progresif MDS�de Proteomic Olgu �al��malar�: Heterojenite ve Daha da �ok Heterojenite

Klara Pecankova, Jaroslav Cermak, Pavel Majek
Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Anahtar Kelimeler: Myelodisplastik sendrom, Plazma proteomu, Proteomikler

Klara Pecankova, Jaroslav Cermak, Pavel Majek. Proteomic Case Studies of MDS in Progression: Heterogeneity and More Heterogeneity. Turk J Hematol. 2022; 39(4): 272-274

Corresponding Author: Pavel Majek, T�rkiye

TOOLS

Full Text PDF

Download citation

RIS

EndNote

BibTex

Medlars

Procite

Reference Manager

Share with email

Send email to author

Similar articles

PubMed

Google Scholar

In authors and institutes

In titles and abstracts

In keywords

In all


	E-ISSN: 1308-5263
Archive Most Accessed Articles Most Cited Articles Aims and Scope Instructions For Authors Editorial Board Advisory Board Manuscript Submission Why to Submit Search Contact